You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Histone Deacytelase Inhibitors

Showing 1 - 25 of 4,414
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV Trial in Puerto Rico, United States (Tamoxifen, Vorinostat, Antiretroviral drugs)

Active, not recruiting
Has Results
  • HIV Infections
  • Birmingham, Alabama
  • +13 more
Jan 13, 2022

Sarcoma Trial in Guangzhou (chidamide and toripalimab)

Recruiting
  • Sarcoma
  • chidamide and toripalimab
  • Guangzhou, Guangdong, China
    Sun Yat-Sen Univerisity
Sep 4, 2022

Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)

Active, not recruiting
  • Recurrent Chronic Lymphoid Leukemia
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Dec 19, 2022

Osteosarcoma Trial (Tucidinostat, Apatinib)

Not yet recruiting
  • Osteosarcoma
  • Tucidinostat, Apatinib
  • (no location specified)
Nov 5, 2023

Histone Deacetylase (HDAC) Activity Trial in Corvallis (BSE , Garlic oil, BSE)

Terminated
Has Results
  • Histone Deacetylase (HDAC) Activity
  • BSE placebo
  • +3 more
  • Corvallis, Oregon
    Oregon State University
Apr 8, 2019

Chronic Lymphocytic Leukemia Trial in Perugia (ITF2357)

Terminated
  • Chronic Lymphocytic Leukemia
  • Perugia, Italy
    Department of Internal Medicine and Public Health, University of
Jan 18, 2022

Renal Cell Carcinoma Trial in United States (LBH589)

Completed
Has Results
  • Renal Cell Carcinoma
  • Fort Myers, Florida
  • +9 more
Oct 26, 2021

Metastatic Colorectal Cancer Trial in Australia (Sodium Valproate, Panitumumab, Cetuximab)

Recruiting
  • Metastatic Colorectal Cancer
  • Sodium Valproate
  • +2 more
  • Saint Leonards, New South Wales, Australia
  • +8 more
Jan 22, 2023

Malignant Tumor, Malignant Tumor of Brain Trial in Taiwan (NBM-BMX Capsule, Temozolomide, Standard radiotherapy)

Recruiting
  • Malignant Neoplasm
  • Malignant Neoplasm of Brain
  • NBM-BMX Capsule
  • +2 more
  • Hualien City, Taiwan
  • +4 more
Aug 22, 2023

Polycystic Ovary Syndrome Trial in Hyderabad (laparoscopy / laparotomy, NO INTERVENTION)

Not yet recruiting
  • Polycystic Ovary Syndrome
  • laparoscopy / laparotomy
  • NO INTERVENTION
  • Hyderabad, Telangana, India
    Dr. Shraddha Ramchandani
Oct 25, 2023

Hepatocellular Carcinoma (HCC) Trial in Taiwan (Chidamide, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma (HCC)
  • Kaohsiung, Taiwan
  • +4 more
Mar 14, 2023

Multiple Myeloma, Myeloma, Myeloma Multiple Trial in United States (KTX-1001)

Recruiting
  • Multiple Myeloma
  • +2 more
  • Scottsdale, Arizona
  • +5 more
Jan 12, 2023

Non Small Cell Lung Cancer Trial in United States (HBI-8000 in combination with pembrolizumab)

Active, not recruiting
  • Non Small Cell Lung Cancer
  • HBI-8000 in combination with pembrolizumab
  • Goodyear, Arizona
  • +6 more
Dec 5, 2022

Advanced Lymphoma, Advanced Malignant Solid Tumor, Advanced Pancreatic Carcinoma Trial in New Haven (BET Bromodomain Inhibitor

Recruiting
  • Advanced Lymphoma
  • +13 more
  • BET Bromodomain Inhibitor ZEN-3694
  • +2 more
  • New Haven, Connecticut
    Yale University Cancer Center LAO
Jun 29, 2022

Thrombocytopenia Trial (Chidamide, HD-DXM)

Not yet recruiting
  • Thrombocytopenia
  • (no location specified)
Jun 6, 2022

HIV-1-infection Trial in Rotterdam (Valproic Acid, Pyrimethamine)

Completed
  • HIV-1-infection
  • Rotterdam, Netherlands
    Erasmus MC
Apr 28, 2021

Castration-Resistant Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 Trial in Seattle

Not yet recruiting
  • Castration-Resistant Prostate Carcinoma
  • +2 more
  • Biopsy
  • +9 more
  • Seattle, Washington
    Fred Hutch/University of Washington Cancer Consortium
Nov 17, 2023

Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma Trial in Guangzhou

Recruiting
  • Esophageal Squamous Cell Cancer, Adenocarcinoma of Esophagogastric Junction, Gastric Adenocarcinoma
  • Tucidinostat (chidamide) and PD-1 inhibitor （Toripalimab）
  • Guangzhou, Guangdong, China
    Cancer center of Sun Yat-sen University
Jul 20, 2022

Neuroblastoma in Children Trial in Guangzhou (Tucidinostat and etoposide)

Recruiting
  • Neuroblastoma in Children
  • Tucidinostat and etoposide
  • Guangzhou, China
    Sun Yat-sen University
Jun 9, 2022

Safety and Efficacy Trial in Suzhou (Chidamide)

Recruiting
  • Safety and Efficacy
  • Suzhou, Jiangsu, China
    First Affiliated Hospital,Soochow University
Nov 30, 2021

CLL/SLL Trial (lisaftoclax +BTK inhibitor, BTK inhibitor)

Not yet recruiting
  • CLL/SLL
  • lisaftoclax +BTK inhibitor
  • BTK inhibitor
  • (no location specified)
Oct 26, 2023

Delirium After Cardiovascular Surgery

Not yet recruiting
  • Delirium
    • (no location specified)
    Aug 23, 2023

    APL Trial in Shanghai (Chidamide+venetoclax)

    Active, not recruiting
    • APL
    • Shanghai, Shanghai, China
      Jiong HU
    May 30, 2023

    Heart Failure With Normal Ejection Fraction, Left Ventricular Hypertrophy, Aortic Valve Stenosis Trial in Boston

    Recruiting
    • Heart Failure With Normal Ejection Fraction
    • +3 more
    • Boston, Massachusetts
      Massachusetts General Hospital
    Mar 1, 2022

    Acute Myeloid Leukemia Trial in Nanjing (Venclexta 100 MG Oral Tablet)

    Recruiting
    • Acute Myeloid Leukemia
    • Venclexta 100 MG Oral Tablet
    • Nanjing, Jiangsu, China
      The First Affiliated Hospital with Nanjing Medical University
    Jun 11, 2023